UROY vs CCJ
Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
UROY · Uranium Royalty$3.04 ▲ 8.19%
CCJ · Cameco$71.30 ▲ 4.35%
One year, rebased to 100
Each line starts at 100 so growth is directly comparable
- UROY -21.9%
- CCJ -24.2%
Head to head
| Metric | UROY | CCJ |
|---|---|---|
| Price | $3.04 | $71.30 |
| Change today | ▲ 8.19% | ▲ 4.35% |
| Market cap | $1.16B | $31.05B |
| Return, 3 months | -26.4% | -26.7% |
| Return, year to date | -14.1% | -22.1% |
| Return, 1 year | -18.7% | -22.6% |
| P/E (TTM) | 8.0 | 109.9 |
| P/B | 1.2 | 6.0 |
| P/E percentile vs own 5y | 51st | 66th |
| Dividend yield | – | 0.24% |
| Revenue growth (YoY, latest qtr) | +112.9% | -7.2% |
| Net profit growth (YoY) | +1,485.5% | -92.1% |
| Gross margin | 33.1% | 26.9% |
| Operating margin | 30.2% | 14.8% |
| Net margin | 25.9% | 10.2% |
| Return on equity | 9.5% | 5.1% |
| Analyst target vs. price | +48.0% | +77.3% |
| Analyst buy share | 100% | 89% |
| RSI (14) | 35 | 33 |
| 30-day volatility | 60.9% | 49.0% |
| Max drawdown, 1 year | -52.2% | -49.0% |
| Trend read | Strong downtrend | Strong downtrend |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
What the numbers say
- CCJ is the largest of the group by market value.
- UROY has returned the most over the past year.
- UROY carries the lowest trailing P/E.
- UROY is growing revenue fastest.
- UROY keeps the most profit per dollar of sales.
- CCJ has been the calmest stock over the last 30 days.